Partnering with site networks offers a strategic solution to overcome the unique challenges of conducting clinical trials in rare diseases. Limited patient populations, complex recruitment pathways, and the geographic dispersion of expertise often hinder the progress of these trials. By leveraging established relationships, specialized knowledge, and streamlined processes, site networks can enhance trial efficiency, accelerate […]

Read More →

The integration of Electronic Trial Master File (eTMF), Clinical Trial Management System (CTMS), and Electronic Data Capture (EDC) is transforming how clinical trials are planned, managed, and executed. By connecting these systems, organizations can eliminate data silos, reduce manual errors, and ensure real-time information flow across trial stakeholders. This integration enhances regulatory compliance, improves trial […]

Read More →

In clinical trials, traditional feasibility is often assessed through a feasibility questionnaire means figuring out if a planned study can run, whether it’s practically possible, ethically sound, and likely to work at the specific site or within the region where it’s proposed. Beyond the feasibility questionnaire, determining if a clinical trial will work is extremely […]

Read More →

The Drugs Controller General of India (DCGI) heads the Central Drugs Standard Control Organization (CDSCO), overseeing DCGI approval in India, regulation, and quality standards of drugs and clinical trials. As the national regulatory authority, DCGI ensures patient safety and compliance with the Drugs and Cosmetics Act, 1940. DCGI in the Indian pharmaceutical and medical device […]

Read More →

Site engagement plays a key role in the success of clinical trials. Starting engagement at the right time and managing it well can make the trial process easier and more efficient. Using engagement strategies from the planning stage to post-trial collaboration helps overcome challenges like patient recruitment, ensures compliance, and improves data quality. This approach […]

Read More →

Global trials are critical for developing orphan drugs because they provide the necessary platform to evaluate the safety, efficacy, and overall impact of these therapies on rare disease populations worldwide. Orphan drugs are specifically designed to treat rare diseases and face unique challenges during development, particularly due to the limited number of patients available for […]

Read More →

The nutraceutical industry has experienced significant growth in recent years, fueled by rising consumer demand for dietary supplements, functional foods, and natural health products. However, with this expansion comes heightened scrutiny from regulatory bodies, highlighting the challenges in nutraceutical clinical trials as a crucial aspect of successfully bringing new products to market. Unlike pharmaceuticals, nutraceuticals […]

Read More →

Thailand is rapidly emerging as a key player in the global clinical trial landscape, with the market expected to reach USD 3.5 billion by 2027. The country’s strategic location in Southeast Asia provides access to a diverse patient population, essential for robust clinical research. Moreover, Thailand’s healthcare system is well-equipped with state-of-the-art facilities and skilled […]

Read More →

Clinical trial site identification and feasibility are critical components of the clinical trial process. Selecting the right sites and ensuring they are feasible for conducting trials can greatly impact the success and efficiency of clinical trials. The process begins with identifying potential sites that have the appropriate infrastructure, patient population, and experience. The right site […]

Read More →